top of page

Videnskabelige studier om mRNA

Delayed headache after COVID-19

Trombose

COVID-19 Vaccines, A Risk Factor for Cerebral Thrombotic Syndromes

Trombose

COVID-19 vaccine-induced immune thrombotic thrombocytopenia An emerging cause of splanchnic vein thrombosis

Trombose

Covid-19 vaccine- induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma

Trombose

Correlation between COVID-19 vaccination and inflammatory musculoskeletal

Trombose

Cerebral venous thrombosis after vaccination against COVID-19 in the UK a multicentre cohort study

Trombose

Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination

Trombose

Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine An analysis of European data

Trombose

Autoimmunity roots of the thrombotic events after COVID-19 vaccination

Trombose

Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia

Trombose

Adverse events following COVID-19 mRNA vaccines, A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia

Trombose

Acute Coronary Tree Thrombosis After Vaccination for COVID-19

Trombose

A Case of Idiopathic Thrombocytopenic Purpura

Trombose

A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine

Trombose

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2020

Trombose

“Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome”

Trombose

Antibody–Fc FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1 PD-L1 Blockade

Cancer

A Case Report of Acute Lymphoblastic Leukaemia (ALL) Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty

Cancer

A case of metastatic BRAFV600-mutated melanoma with heart failure treated with immune checkpoint inhibitors and BRAF MEK inhibitors

Cancer

A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer, pitfall in managing immune-related adverse events

Cancer
bottom of page